385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Diclofenac diethylammonium 1.16% gel 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 7mg/24hours transdermal patches (Pierre Fabre Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 21mg/24hours transdermal patches (Pierre Fabre Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 7mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicopatch 21mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eldoquin 2% cream (Crawford Pharmaceuticals) 28.35 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Adapalene 0.1% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (UniChem Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (UniChem Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (UniChem Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Kent Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Kent Pharma (UK) Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Kent Pharma (UK) Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen Pain Relief Maximum Strength 10% gel (Numark Management Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (A A H Pharmaceuticals Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (A A H Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen Pain Relief Maximum Strength 10% gel (Numark Management Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Teva UK Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rozex 0.75% cream (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lythrin 1% creme rinse (Ovelle Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rozex 0.75% cream (Waymade Healthcare Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lythrin 1% creme rinse (Ovelle Pharmaceuticals) 59 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lythrin 1% creme rinse (Ovelle Pharmaceuticals) 118 ml 2 x 59ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g cream (UniChem Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 25micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 50micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 75micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 100micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g cream (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g cream (UniChem Ltd) 120 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 25micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 50micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 75micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentalis Reservoir 100micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g cream (A A H Pharmaceuticals Ltd) 120 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (A A H Pharmaceuticals Ltd) 118 ml 2 x 59ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (A A H Pharmaceuticals Ltd) 59 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Sandoz Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Balneum 84.75% bath oil (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous cream (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Balneum 84.75% bath oil (Dowelhurst Ltd) 1000 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous cream (Dowelhurst Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (UniChem Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Genus Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dermovate 0.05% cream (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diprosalic scalp application (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Urea 10% cream 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (UniChem Ltd) 59 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 1% scalp application (UniChem Ltd) 118 ml 2 x 59ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Genus Pharmaceuticals Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Genus Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dermovate 0.05% cream (Dowelhurst Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diprosalic scalp application (Dowelhurst Ltd) 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% ointment (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Solaraze 3% gel (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vaniqa 11.5% cream (Dowelhurst Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Dowelhurst Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Dowelhurst Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% ointment (Dowelhurst Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% ointment (Dowelhurst Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Solaraze 3% gel (Dowelhurst Ltd) 25 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vaniqa 11.5% cream (Dowelhurst Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diprosone 0.05% cream (Organon Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Synalar 1 in 4 Dilution 0.00625% cream (GP Pharma)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nystan 100,000units/gram cream (Bristol-Myers Squibb Pharmaceuticals Limited)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nizoral 2% shampoo (Thornton & Ross Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betnovate-N cream (GlaxoSmithKline)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid Forte 10% gel (Goldshield Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous cream (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibugel Forte 10% gel (Dermal Laboratories Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Differin 0.1% cream (Galderma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Quinoderm cream (Ferndale Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous calamine cream (Thornton & Ross Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Alpharma Limited)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dermovate 0.05% cream (GlaxoSmithKline)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Difflam 3% cream (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Kent Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 5 Aquagel (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Drapolene cream (Pfizer Consumer Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nurofen Maximum Strength 10% gel (Crookes Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Unichem Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil 1% cream (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Daktarin Gold 2% cream (McNeil Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Emulsifying ointment (Thornton & Ross Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
NiQuitin CQ Clear 21mg patches (GlaxoSmithKline Consumer Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Emulsifying ointment (Alpharma Limited)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alphosyl cream (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 15 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module